Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genomic Prediction
North Brunswick, New Jersey, United Stateslifeview.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Genomic Prediction’s LifeView platform is commercially available and has demonstrated improved accuracy in embryo selection compared to conventional preimplantation genetic testing. Clinical studies have shown higher pregnancy rates and lower miscarriage rates using their tests. The company is the first to offer polygenic disorder preimplantation genetic testing at scale[1][4].
- Therapeutic areas
- Rare DiseasesWomen's Health
- Modalities
- Diagnostic testGenetic screening
- Industry
- Molecular Diagnostics
02
Partnerships
Not explicitly listed; collaborates with fertility clinics globally[1].
Beyond the preview
Go deeper on Genomic Prediction.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genomic Prediction.